Green Tea And COX-2 Inhibitors Combine To Slow Growth Of Prostate Cancer
Green Tea And COX-2 Inhibitors Combine To Slow Growth Of Prostate Cancer
In the March 1 issue of Clinical Cancer Research, researchers from University of Wisconsin-Madison demonstrate that low doses of the COX-2 inhibitor celecoxib, administered with a green tea polyphenol called pigallocatechin-3-gallate (EGCG), can slow the growth of human prostate cancer. Their experiments were performed in cell cultures and in a mouse model for the disease.
Interesting look at alternative/nutritional solutions alongside pharmaceuticals.